Daruma Capital Management Holds Holding in Pacira Pharmaceuticals (PCRX); Honeywell International (HON) Position Has Lifted by Wallington Asset Management Llc

February 19, 2018 - By Evgen Dobrzhanskiy

Mariko Gordon increased its stake in Pacira Pharmaceuticals Inc (PCRX) by 8.98% based on its latest 2017Q3 regulatory filing with the SEC. Daruma Capital Management Llc bought 100,730 shares as the company’s stock rose 10.53% with the market. The hedge fund run by Mariko Gordon held 1.22 million shares of the health care company at the end of 2017Q3, valued at $45.91 million, up from 1.12M at the end of the previous reported quarter. Daruma Capital Management Llc who had been investing in Pacira Pharmaceuticals Inc for a number of months, seems to be bullish on the $1.22B market cap company. The stock decreased 16.48% or $5.95 during the last trading session, reaching $30.15. About 3.92M shares traded or 342.64% up from the average. Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) has risen 12.40% since February 19, 2017 and is uptrending. It has underperformed by 4.30% the S&P500.

Wallington Asset Management Llc increased its stake in Honeywell International Inc. (HON) by 10.2% based on its latest 2017Q3 regulatory filing with the SEC. Wallington Asset Management Llc bought 5,785 shares as the company’s stock rose 5.49% with the market. The institutional investor held 62,505 shares of the o.e.m. company at the end of 2017Q3, valued at $8.86M, up from 56,720 at the end of the previous reported quarter. Wallington Asset Management Llc who had been investing in Honeywell International Inc. for a number of months, seems to be bullish on the $115.83 billion market cap company. The stock increased 0.40% or $0.61 during the last trading session, reaching $154.03. About 2.80 million shares traded. Honeywell International Inc. (NYSE:HON) has risen 17.66% since February 19, 2017 and is uptrending. It has outperformed by 0.96% the S&P500.

Wallington Asset Management Llc, which manages about $499.10 million and $376.94 million US Long portfolio, decreased its stake in Kimberly (NYSE:KMB) by 2,939 shares to 59,155 shares, valued at $6.96 million in 2017Q3, according to the filing.

Among 21 analysts covering Honeywell International Inc. (NYSE:HON), 17 have Buy rating, 0 Sell and 4 Hold. Therefore 81% are positive. Honeywell International Inc. had 91 analyst reports since July 30, 2015 according to SRatingsIntel. RBC Capital Markets downgraded the stock to “Hold” rating in Wednesday, January 3 report. The stock of Honeywell International Inc. (NYSE:HON) earned “Buy” rating by Jefferies on Tuesday, September 26. RBC Capital Markets maintained the shares of HON in report on Monday, April 24 with “Outperform” rating. The rating was maintained by Barclays Capital with “Overweight” on Monday, November 16. Robert W. Baird initiated Honeywell International Inc. (NYSE:HON) rating on Thursday, October 6. Robert W. Baird has “Outperform” rating and $135 target. Stifel Nicolaus maintained it with “Buy” rating and $165.0 target in Thursday, February 15 report. Jefferies maintained the stock with “Buy” rating in Sunday, January 28 report. Vetr downgraded the shares of HON in report on Friday, August 28 to “Strong-Buy” rating. Credit Suisse maintained the shares of HON in report on Tuesday, July 25 with “Hold” rating. The stock of Honeywell International Inc. (NYSE:HON) has “Hold” rating given on Monday, April 24 by Credit Suisse.

Since August 23, 2017, it had 0 insider purchases, and 1 sale for $426,291 activity. Gautam Rajeev sold $798,211 worth of stock.

Investors sentiment increased to 1.14 in Q3 2017. Its up 0.18, from 0.96 in 2017Q2. It is positive, as 42 investors sold HON shares while 453 reduced holdings. 99 funds opened positions while 465 raised stakes. 562.75 million shares or 0.04% less from 562.97 million shares in 2017Q2 were reported. The Illinois-based Guggenheim Cap Ltd Llc has invested 0.13% in Honeywell International Inc. (NYSE:HON). Lumbard And Kellner Limited Co has invested 0.42% in Honeywell International Inc. (NYSE:HON). South State Corp owns 71,857 shares for 1.14% of their portfolio. Dowling Yahnke Ltd Limited Liability Company accumulated 0.73% or 50,572 shares. Dynamic Capital Management owns 3,341 shares or 0.14% of their US portfolio. Cambridge owns 205,890 shares. Global X Mgmt Co Ltd Com has invested 0.05% of its portfolio in Honeywell International Inc. (NYSE:HON). First City Mngmt Inc owns 10,245 shares for 1.02% of their portfolio. Federated Investors Pa has invested 0.01% of its portfolio in Honeywell International Inc. (NYSE:HON). Pinnacle Llc has 500 shares. 13,555 are held by Advisory Services Ntwk Limited Co. Fiduciary Trust accumulated 0.11% or 26,160 shares. Crestpoint Capital Mgmt Ltd Llc accumulated 3,300 shares. 742,577 were reported by Us Bank & Trust De. Bb&T has invested 0.63% in Honeywell International Inc. (NYSE:HON).

Since August 22, 2017, it had 0 buys, and 2 selling transactions for $1.18 million activity. Another trade for 1,044 shares valued at $37,741 was sold by HASTINGS PAUL J. 340 shares valued at $14,858 were sold by Riker Lauren Bullaro on Friday, December 15.

Investors sentiment decreased to 1.39 in 2017 Q3. Its down 0.23, from 1.62 in 2017Q2. It is negative, as 35 investors sold PCRX shares while 37 reduced holdings. 29 funds opened positions while 71 raised stakes. 41.63 million shares or 5.80% more from 39.35 million shares in 2017Q2 were reported. Sg Americas Secs Ltd owns 0% invested in Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) for 10,559 shares. 6,860 were reported by Denver Investment Advisors Limited. 29,934 were accumulated by Manufacturers Life The. Alps invested in 0.01% or 39,731 shares. Jacobs Levy Equity Mgmt reported 0.01% in Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX). Alyeska Invest Gru LP holds 0.19% of its portfolio in Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) for 638,943 shares. Wells Fargo And Mn invested 0% in Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX). Retail Bank Of Mellon holds 236,058 shares. Guggenheim Cap Ltd Llc holds 79,122 shares. California Employees Retirement Sys reported 65,900 shares stake. Patten Grp Incorporated invested 0% in Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX). Piermont Capital Mgmt holds 0.09% or 6,860 shares in its portfolio. Washington-based Parametric Port Assoc Llc has invested 0% in Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX). Glenmede Tru Na reported 79 shares stake. Point72 Asia (Hong Kong) has 0% invested in Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX).

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: